Levofloxacin Zur Anwendung Bei Erwachsenen Dr. Eberth (Levofloxacin Hemihydrate)

Levofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By blocking these targets, the drug prevents bacterial DNA from unwinding and resealing, leading to bacterial cell death and a bactericidal effect.

The specific dose and duration of levofloxacin therapy are determined by the prescribing clinician based on the infection type, severity, patient renal function, and other clinical factors. Dosage regimens are not standardized in this description.

Levofloxacin is classified as a pregnancy category with unknown risk. It should only be used during pregnancy or lactation if the potential benefits justify the potential risks to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and the necessary import documentation.

Levofloxacin offers broad‑spectrum activity against both Gram‑positive and Gram‑negative bacteria and has the convenience of once‑daily dosing for many indications. Compared with older fluoroquinolones, it provides enhanced potency against certain resistant strains, but shares class‑related safety considerations such as tendon toxicity and QT prolongation.

Levofloxacin intravenous solution should be stored at temperatures below 25 °C, protected from moisture and light, and kept in its original packaging until use. Do not freeze the product, and follow any additional handling instructions provided by the manufacturer.

Levofloxacin is administered intravenously by a healthcare professional. The infusion is typically given over a short period, following aseptic technique, and the exact rate and volume are determined by the prescribing clinician based on the patient’s clinical status.

Serious risks include tendon rupture or tendinitis, QT interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, hepatic dysfunction, and seizures, particularly in patients with pre‑existing central nervous system disorders.

Levofloxacin should be avoided in patients with a known hypersensitivity to fluoroquinolones, a history of tendon disorders related to fluoroquinolone use, significant QT prolongation, or those taking medications that strongly interact with its metabolism. Clinicians must assess each patient’s medical history before prescribing.